Companies / Kuwait
Hikma Expecting MENA sales To Take Off
July 2006 | Company Finance AlertJordanian drugmaker Hikma is aiming to double or even triple its sales in Middle East and North Africa (MENA) in the coming years by acquiring companies and expanding existing businesses. According to Chief Executive Samih Darwazah, the company is considering options in Egypt, Morocco and Turkey, and has a budget of around US$250mn. Hikma is currently the fourth largest drugmaker listed on the London Stock Exchange and in March 2006, the company announced a secondary listing on the Dubai International Financial
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.



